Bisphosphonates and risk of subtrochanteric, femoral shaft, and atypical femur fracture: A systematic review and meta-analysis

Increasing Occurrence of Atypical Femoral Fractures Associated With Bisphosphonate Use

(2012) Raphael P. H. Meier et al.   ARCHIVES OF INTERNAL MEDICINE

Clinical correlates of atypical femoral fracture

(2012) Joan C. Lo et al.   BONE

Incidence and demography of femur fractures with and without atypical features

(2012) Adrianne C Feldstein et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Incidence of atypical nontraumatic diaphyseal fractures of the femur

(2012) Richard M Dell et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Bisphosphonates for Osteoporosis — Where Do We Go from Here?

(2012) Marcea Whitaker et al.   NEW ENGLAND JOURNAL OF MEDICINE

Continuing Bisphosphonate Treatment for Osteoporosis — For Whom and for How Long?

(2012) Dennis M. Black et al.   NEW ENGLAND JOURNAL OF MEDICINE

Atypical fractures and bisphosphonate therapy: A cohort study of patients with femoral fracture with radiographic adjudication of fracture site and features

(2011) Andrea Giusti et al.   BONE

Hip and Subtrochanteric or Diaphyseal Femoral Fractures in Alendronate Users: A 10-Year, Nationwide Retrospective Cohort Study in Taiwanese Women

(2011) Fei-Yuan Hsiao et al.   CLINICAL THERAPEUTICS

Bisphosphonate Use and the Risk of Subtrochanteric or Femoral Shaft Fractures in Older Women

(2011) Laura Y. Park-Wyllie   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Bisphosphonate Use and Atypical Fractures of the Femoral Shaft

(2011) Jörg Schilcher et al.   NEW ENGLAND JOURNAL OF MEDICINE

Estimating bisphosphonate use and fracture reduction among US women aged 45 years and older, 2001-2008

(2010) Ethel S Siris et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the american society for bone and mineral Research

(2010) Elizabeth Shane et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Oral bisphosphonates and risk of subtrochanteric or diaphyseal femur fractures in a population-based cohort

(2010) Seo Young Kim et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Trends in Incidence of Subtrochanteric Fragility Fractures and Bisphosphonate Use Among the US Elderly, 1996-2007

(2010) Zhong Wang et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Cumulative Alendronate Dose and the Long-Term Absolute Risk of Subtrochanteric and Diaphyseal Femur Fractures: A Register-Based National Cohort Analysis

(2010) Bo Abrahamsen et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Bisphosphonates and Fractures of the Subtrochanteric or Diaphyseal Femur

(2010) Dennis M. Black et al.   NEW ENGLAND JOURNAL OF MEDICINE

Risk of femoral shaft and subtrochanteric fractures among users of bisphosphonates and raloxifene

(2010) P. Vestergaard et al.   OSTEOPOROSIS INTERNATIONAL

Efficacy of Bisphosphonates in Reducing Fracture Risk in Postmenopausal Osteoporosis

(2009) John P. Bilezikian   AMERICAN JOURNAL OF MEDICINE

Fragility fractures of the hip and femur: incidence and patient characteristics

(2009) J. W. Nieves et al.   OSTEOPOROSIS INTERNATIONAL

Subtrochanteric and Diaphyseal Femur Fractures in Patients Treated With Alendronate: A Register-Based National Cohort Study

(2008) Bo Abrahamsen et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study

(2008) B. A. Lenart et al.   OSTEOPOROSIS INTERNATIONAL

Suppressed Bone Turnover by Bisphosphonates Increases Microdamage Accumulation and Reduces Some Biomechanical Properties in Dog Rib

(2006) Tasuku Mashiba et al.   JOURNAL OF BONE AND MINERAL RESEARCH